Skip to main content

Company Inception Activities for FLAG Therapeutics, Inc.

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Mar 20, 2014
Award amount: 
Organization name: 
FLAG Therapeutics Inc
Principal Investigator: 
Sorgi, Frank L
Grant program category: 
Business Financing
Grant program name: 
Company Inception Loan
Research Triangle

FLAG Therapeutics is developing novel small molecules with multiple activities on one molecule. FLAG's first platform of compounds shuts off the blood supply to the tumor and kills the tumor with an anticancer agent. The second platform kills tumor by specifically targeting a folate receptor which is unique to tumors.

Fiscal year: